Effect of Testosterone on Cisplatin-induced Nephrotoxicity in Surgically Castrated Rats

Overview

Journal Nephrourol Mon

Publisher Brieflands

Specialty Nephrology

Date 2015 Feb 20

PMID 25695037

Citations 12

Authors

Bahar Rostami

Mehdi Nematbakhsh

Zahra Pezeshki

Ardeshir Talebi

Mohammad Reza Sharifi

Fatemeh Moslemi

Fatemeh Eshraghi-Jazi

Farzaneh Ashrafi

Affiliations

Soon will be listed here.

Abstract

Background: Cisplatin (CP) is an important antitumor drug with serious side effects such as nephrotoxicity. Estrogens can affect CP-induced nephrotoxicity; however, the role of testosterone (TS), the main male sex hormone, is not clear.

Objectives: This study aimed to investigate the effect of TS on CP-induced nephrotoxicity in castrated male rats.

Materials And Methods: A total of 54 male Wistar rats were castrated and allocated into eight groups. Groups 1 through 3 respectively received 10, 50, and 100 mg/kg/wk of TS and group 4 received sesame oil for four weeks; then all four groups received 2.5 mg/kg/d CP for one week. Groups 5 through 8 received the same treatment regimen as groups 1 through 4 during first four weeks but instead of CP, they received saline for one week. Then the animals were sacrificed for biochemical and histopathologic studies.

Results: CP increased the serum levels of blood urea nitrogen (BUN), creatinine (Cr), and malondialdehyde (SMDA) as well as kidney weight (KW), bodyweight (BW) loss, and kidney tissue damage score (KTDS). It significantly decreased the serum and kidney levels of nitrite and serum level of TS in comparison with the control group (P < 0.05). However, coadministration of CP and low dose of TS significantly decreased the serum levels of BUN as well as Cr and KTDS (P < 0.05). Administration of high-dose TS alone increased the SMDA level, KTDS, and KW while decreased the BW significantly (P < 0.05).

Conclusions: It seems that testosterone in low dose, i.e. physiologic dose, protects kidneys against CP-induced nephrotoxicity; however, special care is needed in CP therapy of patients with high levels of TS.

Citing Articles

Effect of hydro-alcoholic extract of on cisplatin-induced memory impairment and brain oxidative stress status in male rats.

Mahmoud Janloo Y, Attari F, Roshan S, Lotfi H, Pezeshki A, Hosseinzadeh M Avicenna J Phytomed. 2024; 14(1):13-22.

PMID: 38948178 PMC: 11210697. DOI: 10.22038/AJP.2023.22789.

The effect of daidzein on renal injury in ovariectomized rats: interaction of angiotensin receptors and long non-coding RNAs H19, GAS5, MIAT, and Rian.

Askaripour M, Najafipour H, Jafarinejad-Farsangi S, Rajabi S, Saberi S, Jafari E Iran J Vet Res. 2023; 24(1):14-21.

PMID: 37378389 PMC: 10291528. DOI: 10.22099/IJVR.2023.43460.6357.

Sex Difference in Cisplatin-Induced Nephrotoxicity: Laboratory and Clinical Findings.

Eshraghi-Jazi F, Nematbakhsh M J Toxicol. 2022; 2022:3507721.

PMID: 36263084 PMC: 9576433. DOI: 10.1155/2022/3507721.

Histoprotective Effect of Essential Oil from in Testosterone-Induced Benign Prostatic Hyperplasia Rat.

Acheampong D, Barffour I, Boye A, Asiamah E, Armah F, Adokoh C Adv Urol. 2019; 2019:3031609.

PMID: 31662741 PMC: 6778952. DOI: 10.1155/2019/3031609.

Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges.

Perse M, Veceric-Haler Z Biomed Res Int. 2018; 2018:1462802.

PMID: 30276200 PMC: 6157122. DOI: 10.1155/2018/1462802.

References

Kyriazis J, Tzanakis I, Stylianou K, Katsipi I, Moisiadis D, Papadaki A . Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant. 2011; 26(9):2971-7. DOI: 10.1093/ndt/gfq847. View

Maheshwari R, Sailor G, Patel L, Balaraman R . Amelioration of cisplatin-induced nephrotoxicity by statins. Indian J Pharmacol. 2013; 45(4):354-8. PMC: 3757603. DOI: 10.4103/0253-7613.115016. View

Stakisaitis D, Dudeniene G, Jankunas R, Grazeliene G, Didziapetriene J, Pundziene B . Cisplatin increases urinary sodium excretion in rats: gender-related differences. Medicina (Kaunas). 2010; 46(1):45-50. View

Nematbakhsh M, Ebrahimian S, Tooyserkani M, Eshraghi-Jazi F, Talebi A, Ashrafi F . Gender difference in Cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than female. Nephrourol Mon. 2013; 5(3):818-21. PMC: 3830908. DOI: 10.5812/numonthly.10128. View

Pezeshki Z, Nematbakhsh M, Nasri H, Talebi A, Pilehvarian A, Safari T . Evidence against protective role of sex hormone estrogen in Cisplatin-induced nephrotoxicity in ovarectomized rat model. Toxicol Int. 2013; 20(1):43-7. PMC: 3702126. DOI: 10.4103/0971-6580.111568. View

Maines M, Sluss P, Iscan M . cis-platinum-mediated decrease in serum testosterone is associated with depression of luteinizing hormone receptors and cytochrome P-450scc in rat testis. Endocrinology. 1990; 126(5):2398-406. DOI: 10.1210/endo-126-5-2398. View

Davis C, Nick H, Agarwal A . Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol. 2001; 12(12):2683-2690. DOI: 10.1681/ASN.V12122683. View

Winston J, Safirstein R . Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol. 1985; 249(4 Pt 2):F490-6. DOI: 10.1152/ajprenal.1985.249.4.F490. View

Saad F . Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?. Diabetes Metab Res Rev. 2013; 28 Suppl 2:52-9. DOI: 10.1002/dmrr.2354. View

10.

Saad F, Haider A, Doros G, Traish A . Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity (Silver Spring). 2013; 21(10):1975-81. DOI: 10.1002/oby.20407. View

11.

Appenroth D, Frob S, KERSTEN L, Splinter F, Winnefeld K . Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997; 71(11):677-83. DOI: 10.1007/s002040050444. View

12.

Mooradian A . Antioxidant properties of steroids. J Steroid Biochem Mol Biol. 1993; 45(6):509-11. DOI: 10.1016/0960-0760(93)90166-t. View

13.

Eshraghi-Jazi F, Nematbakhsh M, Nasri H, Talebi A, Haghighi M, Pezeshki Z . The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model. J Res Med Sci. 2012; 16(11):1389-96. PMC: 3430054. View

14.

Rao S, Kini S, Tamler R . Sex hormones and bariatric surgery in men. Gend Med. 2011; 8(5):300-11. DOI: 10.1016/j.genm.2011.05.007. View

15.

Miller R, Tadagavadi R, Ramesh G, Reeves W . Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel). 2011; 2(11):2490-518. PMC: 3153174. DOI: 10.3390/toxins2112490. View

16.

Lu Y, Fu Y, Ge Y, Juncos L, Reckelhoff J, Liu R . The vasodilatory effect of testosterone on renal afferent arterioles. Gend Med. 2012; 9(2):103-11. PMC: 3322301. DOI: 10.1016/j.genm.2012.02.003. View

17.

Allan C, McLachlan R . Androgens and obesity. Curr Opin Endocrinol Diabetes Obes. 2010; 17(3):224-32. DOI: 10.1097/MED.0b013e3283398ee2. View

18.

Kim J, Kil I, Seok Y, Yang E, Kim D, Lim D . Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice. A role for manganese superoxide dismutase. J Biol Chem. 2006; 281(29):20349-56. DOI: 10.1074/jbc.M512740200. View

19.

Saleh S, El-Demerdash E . Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide. Basic Clin Pharmacol Toxicol. 2005; 97(2):91-7. DOI: 10.1111/j.1742-7843.2005.pto_114.x. View

20.

Arany I, Safirstein R . Cisplatin nephrotoxicity. Semin Nephrol. 2003; 23(5):460-4. DOI: 10.1016/s0270-9295(03)00089-5. View